Literature DB >> 21071508

Use of NBD-cholesterol to identify a minor but NPC1L1-independent cholesterol absorption pathway in mouse intestine.

Michelle R Adams1, Eddy Konaniah, James G Cash, David Y Hui.   

Abstract

The importance of Niemann-Pick C1 Like-1 (NPC1L1) protein in intestinal absorption of dietary sterols, including both cholesterol and phytosterols, is well documented. However, the exact mechanism by which NPC1L1 facilitates cholesterol transport remains controversial. This study administered 22-(N(-7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23,24-bisnor-5-cholen-3β-ol (NBD-cholesterol) and [(3)H]cholesterol to Npc1l1(+/+) and Npc1l1(-/-) mice to determine whether NPC1L1 facilitates dietary sterol uptake by enterocytes and/or participates in intracellular sterol delivery to the endoplasmic reticulum (ER) for lipoprotein assembly before secretion into plasma circulation. Results showed that [(3)H]cholesterol absorption was reduced but not abolished in Npc1l1(-/-) mice compared with Npc1l1(+/+) mice. In the presence of Pluronic L-81 to block pre-chylomicron exit from the ER, significant amounts of [(3)H]cholesterol were found to be associated with lipid droplets in the intestinal mucosa of both Npc1l1(+/+) and Npc1l1(-/-) mice, and the intracellular [(3)H]cholesterol can be esterified to cholesteryl esters. These results provided evidence indicating that the main function of NPC1L1 is to promote cholesterol uptake from the intestinal lumen but that it is not necessary for intracellular cholesterol transport to the ER. Surprisingly, NBD-cholesterol was taken up by intestinal mucosa, esterified to NBD-cholesteryl esters, and transported to plasma circulation to similar extent between Npc1l1(+/+) and Npc1l1(-/-) mice. Ezetimibe treatment also had no impact on NBD-cholesterol absorption by Npc1l1(+/+) mice. Thus, NBD-cholesterol absorption proceeds through an NPC1L1-independent and ezetimibe-insensitive sterol absorption mechanism. Taken together, these results indicate that NBD-cholesterol can be used to trace the alternative cholesterol absorption pathway but is not suitable for tracking NPC1L1-mediated cholesterol absorption.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071508      PMCID: PMC3025510          DOI: 10.1152/ajpgi.00392.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  32 in total

1.  ACC/AHA/NHLBI clinical advisory on the use and safety of statins.

Authors:  Richard C Pasternak; Sidney C Smith; C Noel Bairey-Merz; Scott M Grundy; James I Cleeman; Claude Lenfant
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

2.  Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study.

Authors:  Jørgen Jeppesen; Tine Willum Hansen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen
Journal:  Atherosclerosis       Date:  2006-01-23       Impact factor: 5.162

3.  Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal.

Authors:  Li Yang; Xiaoming Li; Yong Ji; Alison B Kohan; David Q-H Wang; Philip N Howles; David Y Hui; Jianghua Lai; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-22       Impact factor: 4.052

4.  Inhibition of intestinal cholesterol absorption by ezetimibe in humans.

Authors:  Thomas Sudhop; Dieter Lütjohann; Annette Kodal; Michael Igel; Diane L Tribble; Sukrut Shah; Inna Perevozskaya; Klaus von Bergmann
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

Review 5.  Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.

Authors:  Gerd Schmitz; Wolfgang Drobnik
Journal:  Clin Chem Lab Med       Date:  2003-04       Impact factor: 3.694

6.  Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.

Authors:  Louise A Donnelly; Colin N A Palmer; Adrian L Whitley; Chim Choy Lang; Alex S F Doney; Andrew D Morris; Peter T Donnan
Journal:  Pharmacogenet Genomics       Date:  2008-04       Impact factor: 2.089

7.  Kinetic imaging of NPC1L1 and sterol trafficking between plasma membrane and recycling endosomes in hepatoma cells.

Authors:  Nicole Hartwig Petersen; Nils J Faergeman; Nils J Faegeman; Liqing Yu; Daniel Wüstner
Journal:  J Lipid Res       Date:  2008-06-03       Impact factor: 5.922

8.  The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.

Authors:  Liang Ge; Jing Wang; Wei Qi; Hong-Hua Miao; Jian Cao; Yu-Xiu Qu; Bo-Liang Li; Bao-Liang Song
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

9.  Multiple plasma membrane receptors but not NPC1L1 mediate high-affinity, ezetimibe-sensitive cholesterol uptake into the intestinal brush border membrane.

Authors:  Martin Knöpfel; Joanna P Davies; Phu T Duong; Lisbet Kvaernø; Erick M Carreira; Michael C Phillips; Yiannis A Ioannou; Helmut Hauser
Journal:  Biochim Biophys Acta       Date:  2007-06-23

10.  BODIPY-cholesterol: a new tool to visualize sterol trafficking in living cells and organisms.

Authors:  Maarit Hölttä-Vuori; Riikka-Liisa Uronen; Jarmila Repakova; Emppu Salonen; Ilpo Vattulainen; Pertti Panula; Zaiguo Li; Robert Bittman; Elina Ikonen
Journal:  Traffic       Date:  2008-07-19       Impact factor: 6.215

View more
  5 in total

1.  Physiological role of hepatic NPC1L1 in human cholesterol and lipoprotein metabolism: new perspectives and open questions.

Authors:  Philip N Howles; David Y Hui
Journal:  J Lipid Res       Date:  2012-08-31       Impact factor: 5.922

Review 2.  Role of the gut in lipid homeostasis.

Authors:  Nada A Abumrad; Nicholas O Davidson
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.

Authors:  Jen-Chieh Chuang; Mark A Valasek; Adam M Lopez; Kenneth S Posey; Joyce J Repa; Stephen D Turley
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

4.  NPC1L1-dependent transport of 27-alkyne cholesterol in intestinal epithelial cells.

Authors:  Alexander L Ticho; Nathan Calzadilla; Pooja Malhotra; Hyunjin Lee; Arivarasu Natarajan Anbazhagan; Seema Saksena; Pradeep K Dudeja; Daesung Lee; Ravinder K Gill; Waddah A Alrefai
Journal:  Am J Physiol Cell Physiol       Date:  2021-03-24       Impact factor: 4.249

5.  Whole plant based treatment of hypercholesterolemia with Crataegus laevigata in a zebrafish model.

Authors:  Robert M Littleton; Matthew Miller; Jay R Hove
Journal:  BMC Complement Altern Med       Date:  2012-07-23       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.